Who Buys Vaccine from India — 2202 Importers Behind a $1.0B Market
India's vaccine import market is served by 2202 active buyers who collectively imported $1.0B across 14,355 shipments. NATIONAL PRIMARY HEALTH CARE (NIGERIA) leads with a 4.7% market share, followed by UNICEF SUPPLY DIVISION and NATIONAL VACCINES AND IMMUNIZATION. The top 5 buyers together control 19.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Vaccine Importers — Ranked by Import Value
NATIONAL PRIMARY HEALTH CARE (NIGERIA) is the leading vaccine importer from India, holding a 4.7% share of the $1.0B market across 14,355 shipments from 2202 buyers. The top 5 buyers — NATIONAL PRIMARY HEALTH CARE (NIGERIA), UNICEF SUPPLY DIVISION (CONGO), NATIONAL VACCINES AND IMMUNIZATION (KENYA), D.G. CENTRAL MEDICAL STORES DEPT (BANGLADESH), EXPANDED PROGRAM ON IMMUNIZATION (PAKISTAN) — collectively control 19.3% of total import value.
Top Vaccine Buyers & Importers
Ranked by import value · 2202 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | NATIONAL PRIMARY HEALTH CARENIGERIA TYPBAR TCV-2.5 ML VIALDTP-HEPB-HIB FULLYINACTIVATED POLIOMYELITIS VACCINE B.P. B | $49.3M | 5 | 4.7% |
| 2 | UNICEF SUPPLY DIVISIONCONGO TYPBAR TCV-2.5 ML VIALOTHER MIX VACCINE-VIRAL VACCINE-DTP-HEPB-HIB FULLY | $41.9M | 5 | 4.0% |
| 3 | NATIONAL VACCINES AND IMMUNIZATIONKENYA TYPBAR TCV-2.5 ML VIALDTP-HEPB-HIB FULLYINACTIVATED POLIOMYELITIS VACCINE B.P. B | $38.7M | 5 | 3.7% |
| 4 | D.G. CENTRAL MEDICAL STORES DEPTBANGLADESH MR VACCINE MEASLES AND RUBELLA VACCINE CDTP-HEPB-HIB FULLY | $37.2M | 5 | 3.6% |
| 5 | EXPANDED PROGRAM ON IMMUNIZATIONPAKISTAN TYPBAR TCV-2.5 ML VIAL VLSDTP-HEPB-HIB FULLYTYPBAR TCV-2.5 ML VIAL | $33.4M | 5 | 3.2% |
| 6 | XXRUMXXIFEXXCIEXXES XXDSUDAN NUVAXOVID COVID-19 VACCINENUVAXOVIDINACTIVATED POLIOMYELITIS VACCINE B.P. B | $31.3M | 5 | 3.0% |
| 7 | SERUM LIFE SCIENCES LIMITEDSUDAN TYPBAR TCV-2.5 ML VIALNUVAXOVID COVID-19 VACCINENUVAXOVID | $31.3M | 5 | 3.0% |
| 8 | MINISTRY OF HEALTHGAMBIA TYPBAR TCV-2.5 ML VIALDTP-HEPB-HIB FULLYVACCINE FOR POLIO-POLIOMYELITIS- | $27.6M | 5 | 2.6% |
| 9 | XXICEXXSUPXXY DXXISIXXAFGHANISTAN OTHER MIX VACCINE-VIRAL VACCINE-DTP-HEPB-HIB FULLYVACCINE FOR POLIO-POLIOMYELITIS- | $23.5M | 5 | 2.3% |
| 10 | SERUM LIFE SCIENCES LTDIRELAND TYPBAR TCV-2.5 ML VIALNUVAXOVID COVID-19 VACCINENUVAXOVID | $20.0M | 5 | 1.9% |
| 11 | EXPANDED PROGRAMME ON IMMUNIZATIONPAKISTAN TYPBAR TCV-2.5 ML VIAL VLSDTP-HEPB-HIB FULLYTYPBAR TCV-2.5 ML VIAL | $14.0M | 5 | 1.3% |
| 12 | PERMANENT SECRETARYTANZANIA | $13.3M | 5 | 1.3% |
| 13 | CENTURION ILAC SANAYI VE TICARET ANTURKEY ABHAYRAB 0.5ML B.PMIXED VACCINE FOR MMR-VIRAL VACCINE-ABHAYRAB 0.5MLHUMAN RABIES VACCINE WITH | $12.1M | 5 | 1.2% |
| 14 | PT BIO FARMA PERSERO NAINDONESIA TYPBAR TCV-2.5 ML VIALROTAVAC 2.5ML ROTAVIRUS VACCINE LIVEOROTHER MIX VACCINE-VIRAL VACCINE- | $12.0M | 5 | 1.2% |
| 15 | D G CENTRAL MEDICAL STORES DEPTBANGLADESH TYPBAR TCV-2.5 ML VIALNUVAXOVID COVID-19 VACCINEOTHER MIX VACCINE-VIRAL VACCINE- | $11.8M | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Vaccine — and from which countries?
Flow of Vaccine exports from India: each country's share and the named importers behind the numbers
Vaccine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Pakistan
Pakistan emerges as the first largest importing country, achieving a total trade value of $88.1M through 105 shipments. This represents a market share of 8.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Pakistan has a diverse importer base, with their top importers including:
• EXPANDED PROGRAM ON IMMUNIZATION - $33.4M (37.9% of country's total business)
• EXPANDED PROGRAMME ON IMMUNIZATION - $14.0M (15.9% of country's total business)
• BE VACCINES PTE LIMITED - $10.1M (11.5% of country's total business)
Key Insight: Pakistan demonstrates strong market positioning with an average shipment value of $838.7K, indicating premium pricing strategy compared to the market average of $72.5K.
Pakistan is a key market for Vaccine imports, representing 8.5% of total trade value.
2Nigeria
Nigeria emerges as the second largest importing country, achieving a total trade value of $84.5M through 156 shipments. This represents a market share of 8.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• NATIONAL PRIMARY HEALTH CARE - $49.3M (58.3% of country's total business)
• NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY NPHCDA - $9.4M (11.1% of country's total business)
• NATIONAL PRIMARY HEALTHCARE - $9.3M (11.0% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $541.8K, indicating premium pricing strategy compared to the market average of $72.5K.
Nigeria is a key market for Vaccine imports, representing 8.1% of total trade value.
3Bangladesh
Bangladesh emerges as the third largest importing country, achieving a total trade value of $78.1M through 107 shipments. This represents a market share of 7.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Bangladesh has a diverse importer base, with their top importers including:
• D.G. CENTRAL MEDICAL STORES DEPT - $37.2M (47.7% of country's total business)
• D G CENTRAL MEDICAL STORES DEPT - $11.8M (15.1% of country's total business)
• D.G. CENTRAL MEDICAL STORES DEPT. - $9.9M (12.6% of country's total business)
Key Insight: Bangladesh demonstrates strong market positioning with an average shipment value of $730.0K, indicating premium pricing strategy compared to the market average of $72.5K.
Bangladesh is a key market for Vaccine imports, representing 7.5% of total trade value.
4Kenya
Kenya emerges as the fourth largest importing country, achieving a total trade value of $55.9M through 37 shipments. This represents a market share of 5.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Kenya has a diverse importer base, with their top importers including:
• NATIONAL VACCINES AND IMMUNIZATION - $38.7M (69.2% of country's total business)
Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $1.5M, indicating premium pricing strategy compared to the market average of $72.5K.
Kenya is a key market for Vaccine imports, representing 5.4% of total trade value.
5Philippines
Philippines emerges as the fifth largest importing country, achieving a total trade value of $47.3M through 33 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• 2 WORLD TRADERS INC - $11.0M (23.2% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $72.5K.
Philippines is a key market for Vaccine imports, representing 4.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Vaccine buyer market intelligence
1Buyer Segment Analysis
The importation of vaccines from India involves various buyer segments, each with distinct purchasing behaviors and order patterns. Based on TransData Nexus data from 2022 to 2026, the top 10 buyers can be categorized as follows:
1. Government Procurement Agencies: These entities, such as Nigeria's National Primary Health Care ($49.26M), Kenya's National Vaccines and Immunization ($38.72M), Bangladesh's D.G. Central Medical Stores Department ($37.23M), Pakistan's Expanded Program on Immunization ($33.37M), and Gambia's Ministry of Health ($27.56M), are responsible for national immunization programs. They typically engage in large-scale, periodic purchases aligned with government health initiatives and vaccination schedules.
2. International Organizations: UNICEF Supply Division in Congo ($41.95M) exemplifies this segment, procuring vaccines for distribution in various countries, especially in regions with limited access to healthcare. Their purchasing patterns are characterized by bulk orders to support global immunization efforts.
3. Contract Manufacturers: Entities like Serum Life Sciences Limited in Sudan ($31.32M) and Ireland ($20.05M) fall into this category. They procure vaccines to fulfill manufacturing contracts, often for re-export or to meet specific regional demands. Their orders are typically large and consistent, reflecting ongoing production commitments.
4. Re-exporters: Buyers such as XXRUMXXIFEXXCIEXXES XXD in Sudan ($31.33M) and XXICEXXSUPXXY DXXISIXX in Afghanistan ($23.48M) may act as intermediaries, importing vaccines for redistribution to neighboring regions. Their purchasing behavior includes substantial orders intended for further distribution, often influenced by regional demand fluctuations.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and purchasing patterns of each buyer type.
Country-Specific Import Regulations
TransData Nexus Vaccine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of vaccines from India, the import regulations are as follows:
1. Pakistan:
2. Nigeria:
3. Bangladesh:
4. Kenya:
5. Philippines:
It is essential for exporters to stay updated with the specific regulatory requirements and timelines of each country to ensure compliance and facilitate smooth market entry.
Demand Drivers & Market Opportunity
TransData Nexus Vaccine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for vaccines in importing countries is driven by several key factors:
1. Disease Prevalence: High incidences of vaccine-preventable diseases, such as measles, polio, and hepatitis, necessitate robust immunization programs. For instance, the World Health Organization (WHO) reported a 50% increase in measles cases globally in 2024, underscoring the urgent need for vaccines.
2. Government Healthcare Programs: National immunization initiatives aim to achieve widespread coverage. Countries like Nigeria and Pakistan have launched extensive vaccination campaigns targeting children under five, significantly boosting vaccine demand.
3. Universal Health Coverage Expansion: Efforts to provide comprehensive healthcare access have led to increased vaccine procurement. The Philippines, for example, expanded its Universal Health Care Act in 2025, incorporating broader immunization services.
4. WHO Essential Medicines List Procurement: Inclusion of vaccines in the WHO Essential Medicines List prompts countries to prioritize their procurement, ensuring availability and affordability.
5. Tender-Based Purchasing: Many governments and international organizations utilize tender systems to procure vaccines, fostering competitive pricing and reliable supply chains. UNICEF's Supply Division, a major buyer, regularly issues tenders to meet global immunization needs.
With 2,202 buyers across 192 countries, the global vaccine market presents substantial opportunities for exporters. Understanding the specific demand drivers in each region enables targeted strategies to effectively meet the needs of diverse markets.
Common Questions — Vaccine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest vaccine buyer importing from India?
Based on import volume and value, NATIONAL PRIMARY HEALTH CARE (NIGERIA) leads with $49.3M in imports and a 4.7% market share — the highest of any single vaccine importer. UNICEF SUPPLY DIVISION (CONGO) and NATIONAL VACCINES AND IMMUNIZATION (KENYA) are the next largest buyers.
QHow many companies buy vaccine from India?
There are 2202 active vaccine buyers importing from India, with a combined market of $1.0B across 14,355 shipments to 192 countries. The top 5 buyers hold 19.3% of total import value, while the remaining 2197 buyers handle the other 80.7%.
QWhich countries import the most vaccine from India?
The top importing countries for vaccine from India are Pakistan (8.5%), Nigeria (8.1%), Bangladesh (7.5%), Kenya (5.4%), Philippines (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of vaccine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for vaccine from India?
The average import transaction value for vaccine from India is $72.5K, with an average unit price of $23.48 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Vaccine buyer market intelligence
1Buyer Segment Analysis
The importation of vaccines from India involves various buyer segments, each with distinct purchasing behaviors and order patterns. Based on TransData Nexus data from 2022 to 2026, the top 10 buyers can be categorized as follows:
1. Government Procurement Agencies: These entities, such as Nigeria's National Primary Health Care ($49.26M), Kenya's National Vaccines and Immunization ($38.72M), Bangladesh's D.G. Central Medical Stores Department ($37.23M), Pakistan's Expanded Program on Immunization ($33.37M), and Gambia's Ministry of Health ($27.56M), are responsible for national immunization programs. They typically engage in large-scale, periodic purchases aligned with government health initiatives and vaccination schedules.
2. International Organizations: UNICEF Supply Division in Congo ($41.95M) exemplifies this segment, procuring vaccines for distribution in various countries, especially in regions with limited access to healthcare. Their purchasing patterns are characterized by bulk orders to support global immunization efforts.
3. Contract Manufacturers: Entities like Serum Life Sciences Limited in Sudan ($31.32M) and Ireland ($20.05M) fall into this category. They procure vaccines to fulfill manufacturing contracts, often for re-export or to meet specific regional demands. Their orders are typically large and consistent, reflecting ongoing production commitments.
4. Re-exporters: Buyers such as XXRUMXXIFEXXCIEXXES XXD in Sudan ($31.33M) and XXICEXXSUPXXY DXXISIXX in Afghanistan ($23.48M) may act as intermediaries, importing vaccines for redistribution to neighboring regions. Their purchasing behavior includes substantial orders intended for further distribution, often influenced by regional demand fluctuations.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and purchasing patterns of each buyer type.
Country-Specific Import Regulations
TransData Nexus Vaccine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of vaccines from India, the import regulations are as follows:
1. Pakistan:
2. Nigeria:
3. Bangladesh:
4. Kenya:
5. Philippines:
It is essential for exporters to stay updated with the specific regulatory requirements and timelines of each country to ensure compliance and facilitate smooth market entry.
Demand Drivers & Market Opportunity
TransData Nexus Vaccine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for vaccines in importing countries is driven by several key factors:
1. Disease Prevalence: High incidences of vaccine-preventable diseases, such as measles, polio, and hepatitis, necessitate robust immunization programs. For instance, the World Health Organization (WHO) reported a 50% increase in measles cases globally in 2024, underscoring the urgent need for vaccines.
2. Government Healthcare Programs: National immunization initiatives aim to achieve widespread coverage. Countries like Nigeria and Pakistan have launched extensive vaccination campaigns targeting children under five, significantly boosting vaccine demand.
3. Universal Health Coverage Expansion: Efforts to provide comprehensive healthcare access have led to increased vaccine procurement. The Philippines, for example, expanded its Universal Health Care Act in 2025, incorporating broader immunization services.
4. WHO Essential Medicines List Procurement: Inclusion of vaccines in the WHO Essential Medicines List prompts countries to prioritize their procurement, ensuring availability and affordability.
5. Tender-Based Purchasing: Many governments and international organizations utilize tender systems to procure vaccines, fostering competitive pricing and reliable supply chains. UNICEF's Supply Division, a major buyer, regularly issues tenders to meet global immunization needs.
With 2,202 buyers across 192 countries, the global vaccine market presents substantial opportunities for exporters. Understanding the specific demand drivers in each region enables targeted strategies to effectively meet the needs of diverse markets.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 2202 global importers of Vaccine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 14,355 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 192 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14,355 Verified Shipments
2202 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists